| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.05 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |